Navigation Links
Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
Date:10/3/2007

e program and the aggressive clinical development of its key assets to build stockholder value. http://www.genaera.com.

About MacroChem

MacroChem Corporation is a specialty pharmaceutical company with two clinical development stage products containing our proprietary enhancer, SEPA(R): EcoNail, to treat fungal infection of the nail and Opterone(R), to treat male hypogonadism. In addition to their SEPA technology, MacroChem is also evaluating applications for MacroDerm(TM), their patented series of polymers that impede penetration of active ingredients through the skin. The in-licensing of pexiganan represents the first product under the Company's previously stated strategy to seek such opportunities to complement its proprietary products based on its transdermal drug delivery technologies. For more information visit their website, http://www.macrochem.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. Such statements include, among others, statements regarding these preliminary results, clinical development plans and prospects for Genaera's programs including trodusquemine (MSI-1436), the IL-9 antibody program, LOMUCIN(TM), or squalamine. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to: Genaera
'/>"/>

SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Genaera Discontinues Lomucin in Cystic Fibrosis Studies
2. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
3. PM announces a new health care order for India
4. Ramdoss Announces Introduction of RCH-II
5. Britain Announces Third Transfusion Related Mad Cow Case
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. Tibet Announces the Dalai Lama’s Tour of South Americ
8. NHS announces further Cost cutting Measures
9. Indian PM Announces Of Setting Up India Study Center At Tashkent
10. PowderMed Announces Needle-Less Flu Vaccine
11. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , ... August 27, 2015 , ... Mesa Community ... than 2,100 applicants worldwide, selected based on academic rigor, leadership and engagement, to receive ... a baccalaureate degree. , Sypher will receive a medallion and a $7,500 scholarship to ...
(Date:8/27/2015)... Billings, Montana (PRWEB) , ... August 27, 2015 ... ... Disorders Association, the average annual cost to treat a patient with hemophilia is ... engaged in finding a cure and improving treatment. The RMHBDA exists to help ...
(Date:8/27/2015)... , ... August 27, 2015 , ... According to an ... Conference on Abdominal Wall Hernia Surgery involved many conversations between hernia experts surrounding the ... there, the article notes that many different experts have different ideas about which is ...
(Date:8/27/2015)... ... August 27, 2015 , ... In an article published July ... the city of New Orleans, highlighting a security firm that is tasked with providing ... tech oriented entrepreneur who worked with the city to provide private security when it ...
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny General Hospital (AGH), part ... medical centers in the United States to receive international recognition for an advanced, ... Extracorporeal Life Support Organization (ELSO) , an international consortium of healthcare institutions dedicated ...
Breaking Medicine News(10 mins):Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Recent Article on Hernia Mesh Developments Highlights Viable Options, But Shows a Need for Further Research, notes Dr. Shirin Towfigh 2Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4
... Flomax Is Case Study of How Costly Drugs Drive Up ... According to a new report by Consumer Reports Best Buy ... widely advertised drug Flomax for treating the symptoms of enlarged prostate, and ... the 20 most commonly prescribed drugs in 2008. , ...
... 15 AMDL Inc. (NYSE ... China, announced today the second closing of a private placement offering ... The exclusive placement agent for the offering is Cantone Research ... 2009, AMDL sold $1,327,250 of 12% Series 2 convertible notes at ...
... gives a talk about his research, he begins with the ... supermodel died from severe sepsis in January after amputation of ... Martin, who is a fellow in allergy, pulmonary and ... Vanderbilt University that has come up with a high-tech approach ...
... yeast rice does well in small trial, but there are ... new study revives a running controversy about the purported cholesterol-lowering ... , Red yeast rice is produced when a yeast, ... used in Asian countries for more than a thousand years ...
... infections, heart problems, new advisory says , MONDAY, ... undergoing surgery are at greater risk of heart ... complications, according to a Scientific Advisory from the ... anesthesiologists and other health-care providers underestimate the seriousness ...
... This release is available in French . ... (BWF) has announced the recipients of the 2009 Investigators in ... Saleh was one of six recipients granted $500,000 over a ... of NLR-mediated innate immunity." "We are studying how the body ...
Cached Medicine News:Health News:Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year 2Health News:Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year 3Health News:Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year 4Health News:AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes 2Health News:AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes 3Health News:Vanderbilt researchers pioneer an advanced sepsis detection and management system 2Health News:Vanderbilt researchers pioneer an advanced sepsis detection and management system 3Health News:Vanderbilt researchers pioneer an advanced sepsis detection and management system 4Health News:Vanderbilt researchers pioneer an advanced sepsis detection and management system 5Health News:A Substitute for Those Who Can't Take Statins? 2Health News:A Substitute for Those Who Can't Take Statins? 3Health News:Heart Association Warns of Surgery Risks in Obese 2Health News:MUHC researcher awarded $500,000 to study pathogenesis of infectious disease 2
(Date:8/27/2015)... Md. , Aug. 27, 2015  BioElectronics Corporation (OTC ... announced today that three abstracts featuring the use of ... at the 9 th Congress of the European ... 2-5 th September 2015. The Company will also ... Dr Gianluca Bagnato , department clinical and ...
(Date:8/27/2015)... 27, 2015  PinnacleHealth CardioVascular Institute enrolled the first patient ... the United States in a trial assessing ... for blockages in the main artery of the leg. The ... potentially less risk for stent fracture or re-narrowing after the ... multicenter clinical trial of the BioMimics 3D Stent System and ...
(Date:8/27/2015)... , Aug. 27, 2015   Americord Registry ... tissue , and placenta tissue banking company, ... blood banking e-commerce website. This new website makes the ... with an interactive shopping cart and checkout process. ... "Most cord blood banking websites make this service difficult ...
Breaking Medicine Technology:BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2First Pennsylvania Patient Treated in Landmark Vascular Study 2Cord Blood Bank Revolutionizes Process of Online Cord Blood Banking 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: